Serum total homocysteine concentration before and after renal transplantation

被引:68
作者
Arnadottir, M [1 ]
Hultberg, B
Wahlberg, J
Fellström, B
Dimény, E
机构
[1] Natl Univ Hosp, Dept Med, Div Nephrol, IS-101 Reykjavik, Iceland
[2] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden
[3] Univ Uppsala Hosp, Dept Transplant Surg, Uppsala, Sweden
[4] Univ Uppsala Hosp, Dept Med, Uppsala, Sweden
[5] Univ Umea Hosp, Dept Med, S-90185 Umea, Sweden
关键词
homocysteine; atherosclerosis; glomerular filtration rate; cyclosporine; endothelial toxicity; platelets and coagulation; end-stage renal disease;
D O I
10.1046/j.1523-1755.1998.00112.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Hyperhomocysteinemia is by now an established risk factor for the development of atherosclerosis. Total homocysteine concentration (tHcy) correlates inversely with glomerular filtration rate, and it is roughly three times as high in hemodialysis patients as in healthy individuals. Therefore, tHcy would be expected to fall markedly after successful renal transplantation, Thr aim of the present study was to assess the changes in tHcy associated with renal transplantation. Methods. tHcy was analyzed in samples collected before renal transplantation and at sis months after transplantation in 55 stable patients, all of whom were treated with cyclosporine (CS). tHcy was also analyzed in samples from 55 controls characterized by markers of renal function that matched those of the posttransplant state. Results. At six months after transplantation, tHcy was significantly decreased as compared with pretransplant tHcy (27.7 +/- 14.8 vs. 36.9 +/- 21.3 mu mol/liter. P < 0.001). Post-transplant tHcy was markedly higher than the tHcy of the control group (27.7 +/- 14.8 vs. 16.0 +/- 5.3 mu mol/liter. P < 0.0001). The post-transplant change in tHcy ranged widely, the average change being a reduction of 14%. Sixteen patients (29%) actually manifested an increase in post-transplant tHcy. The post-transplant changes in tHcy correlated inversely with pretransplant tHcy (r = -0.66. r < 0.0001) and directly with the changes in serum albumin concentrations (r = 0.35, P < 0.05) and CS trough concentrations (r = 0.29, P < 0.05). A multivariate analysis, including the posttransplant changes in serum concentrations of folate and albumin as well as creatinine clearances explained 21% of the change in tHcy (P < 0.05). After inclusion of the CS concentration, an independent predictor, the model accounted for 28% of the post-transplant change in tHcy (P < 0.01). Conclusion. The post-transplant reduction in tHcy was far smaller than expected with respect to renal function, and the post-transplant changes in the major biochemical determinants of tHcy contributed relatively little to explain the change in tHcy. Thus, the results suggest the post-transplant introduction of one or more factors that induct an increase in tHcy. Treatment with CS appears to be such a factor.
引用
收藏
页码:1380 / 1384
页数:5
相关论文
共 19 条
  • [1] ANDERSSON A, 1993, CLIN CHEM, V39, P1590
  • [2] Treatment with high-dose folic acid effectively lowers plasma homocysteine concentration in cyclosporine-treated renal transplant recipients
    Arnadottir, M
    Hultberg, B
    [J]. TRANSPLANTATION, 1997, 64 (07) : 1087 - 1087
  • [3] The effect of reduced glomerular filtration rate on plasma total homocysteine concentration
    Arnadottir, M
    Hultberg, B
    NilssonEhle, P
    Thysell, H
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (01) : 41 - 46
  • [4] ARNADOTTIR M, 1993, CLIN NEPHROL, V40, P236
  • [5] Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients
    Arnadottir, M
    Hultberg, B
    Vladov, V
    NilssonEhle, P
    Thysell, H
    [J]. TRANSPLANTATION, 1996, 61 (03) : 509 - 512
  • [6] SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE
    ARNESEN, E
    REFSUM, H
    BONAA, KH
    UELAND, PM
    FORDE, OH
    NORDREHAUG, JE
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) : 704 - 709
  • [7] INCREASE IN TOTAL PLASMA HOMOCYSTEINE CONCENTRATION AFTER CARDIAC TRANSPLANTATION
    BERGER, PB
    JONES, JD
    OLSON, LJ
    EDWARDS, BS
    FRANTZ, RP
    RODEHEFFER, RJ
    KOTTKE, BA
    DALY, RC
    MCGREGOR, CGA
    [J]. MAYO CLINIC PROCEEDINGS, 1995, 70 (02) : 125 - 131
  • [8] NET UPTAKE OF PLASMA HOMOCYSTEINE BY THE RAT-KIDNEY IN-VIVO
    BOSTOM, A
    BROSNAN, JT
    HALL, B
    NADEAU, MR
    SELHUB, J
    [J]. ATHEROSCLEROSIS, 1995, 116 (01) : 59 - 62
  • [9] High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients
    Bostom, AG
    Shemin, D
    Lapane, KL
    Hume, AL
    Yoburn, D
    Nadeau, MR
    Bendich, A
    Selhub, J
    Rosenberg, IH
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (01) : 147 - 152
  • [10] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES
    BOUSHEY, CJ
    BERESFORD, SAA
    OMENN, GS
    MOTULSKY, AG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13): : 1049 - 1057